References
- Braquet, P., Spinnewyn, B., Braquet, M., Bourgain, R.H., Taylor, J.E., Etienne, A., and Drieu, K., BN 52021 and related compounds: a new series of highly specific PAF-acether receptor antagonists isolated from Ginkgobiloba. Blood Vessel. 70, 559-564 (1985)
- Braquet, P, Tougui, L., Shen, T.Y., and Vargaftig B.B., Perspectives in Platelet-activating Factor Research. Pharmacal. Rev. 39, 97-145 (1987)
- Choi, O.J., Components and utilization of herbal medicines. Ilwalsuhgak, Seoul, (1991)
- Curtis, L.M., Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis. Adv. Exp. Med Biol. 416, 361-363 (1996)
- Fan, G.J., Han, B.H., Kang, Y.H., and Park, M.K., Evaluation of inhibitory potentials of Chinese medicinal plants on platelet-activating factor (PAF) receptor binding. Nat. Prod Sci. 7, 33-37 (2001)
- Han, B.H., Yang, H.O., Kang, Y.H., and Han, Y.N., Screening of the inhibitory effect of herbal medicines on the platelet activating factor (PAF) binding: 35 selected herbal medicines based on folk medicinal informations. Kor. J. Pharmacogn. 39, 10-13 (1995) https://doi.org/10.1111/j.1440-1673.1995.tb00223.x
- Hanahan, D.J., Platelet activating factor: A biologically active phosphoglyceride. Annu. Rev. Biachem. 55, 483-509 (1987)
- Hsueh, W., Gonzalez, C.F., and Arrovave, J.L., Platelet activating factor-induced ischemic bowel necrosis. Am. J. Pathol. 122, 231-239 (1986)
- Ito, O., Camussi, G., Tetta, C., Milgrom, F., and Andres, G., Hyperacute renalallograft rejection in the rabbit: the role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leucocytes and from platelets. Lab. Invest. 51, 148-161 (1984)
- Jantan, I.B., Kang, Y.H., Suh, D.Y., and Han, B.H., Inhibitory effect of Malaysian medicinal plants on the platelet activating factor (PAF) binding. Nat. Prod. Sci. 2, 86-89 (1996)
- Jantan, I., Rafi, I.A., and Jalil, J., Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants. Phytomedicine. 12, 88-92 (2005) https://doi.org/10.1016/j.phymed.2003.06.006
- Kloprogge, E., and Akkerman N., Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phophocholine) to intact human platelets. Biochem. J., 223, 901-907 (1984) https://doi.org/10.1042/bj2230901
- Koltai, M., Hosford, D., Guinot, P., Esanu, A., and Braquet, P., Platelet activating factor (PAF). A review of its effects, antagonists, and possible future clinical implications (Part I). Drugs. 42, 9-29 (1991) https://doi.org/10.2165/00003495-199142010-00002
- Maller, A.T. and Cunningham, F.M., Structural identification of platelet activating factor in psoriatic scale. Biochem. Biophys. Res. Commun. 126, 192-235 (1986) https://doi.org/10.1016/0006-291X(85)90590-X
- Snyder, F., Chemical and biochemical aspects of platelet activating factor: anovel class of acetylated ether-linked choline phospholipids, Med Res. Rev. 5, 107-115 (1985) https://doi.org/10.1002/med.2610050105
- Valone, E.H., Coles, E., Reinhold, V.R., and Goetzl, E.J., Specific binding ofphospholipid platelet-activating factor by human platelets. J. lmmunol. 129, 1637-1641 (1982)
- Vargaftig, B.B. and Braquet, P., PAF-acether today: relevance for acute experimental anaphylaxis. Br. Med Bull. 43, 312-319 (1987) https://doi.org/10.1093/oxfordjournals.bmb.a072185